Study of IBI318 in Participants With Advanced Malignancies

Clinical trial NCT03875157 · COMPLETED

Trial details

NCT number: NCT03875157
Sponsor: Innovent Biologics (Suzhou) Co. Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Malignancy

Start date: 2019-04-19
Primary completion: 2023-02-16
Enrollment: 103

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.